Renol Polychem Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹71 Cr
- P/E
- 8.65
- ROE
- 13.56%
- Price to sales
- 0.79
- Debt to equity
- 0.16
- 52W high / low
- ₹154 / ₹52.6
- EBITDA margin
- 13.07%
- Net profit margin
- 9.17%
- Promoter holding
- 51.10%
- Sales (last year)
- ₹90 Cr
Incorporated in 2008, Renol Polychem Limited is a manufacturer and supplier specializing in colour masterbatches, plastic masterbatches, industrial chemicals, impact modifiers, plastic pigments, etc.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹1,858 Cr | 25.8 | |
| 2 | 40%+ | Up 0–2% | ₹234 Cr | 3.0 | |
| 3 | 40%+ | Flat | ₹3,514 Cr | 4.3 | |
| 4 | 40%+ | Flat | ₹2,257 Cr | 30.0 | |
| 5 | 40%+ | Flat | ₹180 Cr | 11.9 | |
| 6 | 40%+ | Flat | ₹138 Cr | 15.1 |
Sign up free to see every company in the sector ranking and track Renol Polychem.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Renol Polychem
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Renol Polychem
Shareholding breakup across reporting periods.
| Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|
| Promoters + | 69.10% | 51.10% | 51.10% |
| FIIs + | 0.68% | 0.00% | 0.00% |
| DIIs + | 3.63% | 0.00% | 0.00% |
| Public + | 26.59% | 48.90% | 48.90% |
| No. of Shareholders | 573 | 599 | 643 |
Financials of Renol Polychem
Quarterly Results
Quarter-by-quarter operating performance
Financials of Renol Polychem
Profit & Loss
Annual income statement trend
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| Sales + | 62 | 90 | 107 |
| Sales growth | +44% | +45% | |
| Expenses + | 55 | 78 | 95 |
| Operating Profit | 7 | 12 | 11 |
| OPM % | 11% | 13% | 11% |
| Other Income + | 0 | 0 | 1 |
| Interest | 1 | 0 | 1 |
| Depreciation | 0 | 1 | 1 |
| Profit before tax | 7 | 11 | 10 |
| Tax % | 25% | 26% | |
| Net Profit + | 5 | 8 | 7 |
| EPS in Rs | 9.11 | 6.83 | 6.13 |
| Dividend Payout % | 0% | 0% |
Financials of Renol Polychem
Balance Sheet
Capital structure and asset base
| Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|
| Equity Capital | 5 | 12 | 12 |
| Reserves | 8 | 96 | 98 |
| Borrowings + | 7 | 17 | 32 |
| Other Liabilities + | 3 | 75 | 71 |
| Total Liabilities | 23 | 201 | 213 |
| Fixed Assets + | 0 | 35 | 34 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 7 | 9 |
| Other Assets + | 23 | 159 | 170 |
| Total Assets | 23 | 201 | 213 |
Financials of Renol Polychem
Cash Flows
Operating, investing and financing cash movement
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity + | -1 | -40 |
| Cash from Investing Activity + | -1 | -61 |
| Cash from Financing Activity + | 4 | 109 |
| Net Cash Flow | 2 | 8 |
| Free Cash Flow | -1 | -89 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 10% | -317% |
Financials of Renol Polychem
Ratios
Working capital efficiency and return ratios
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 53 | 265 |
| Inventory Days | 64 | 258 |
| Days Payable | 8 | 292 |
| Cash Conversion Cycle | 109 | 231 |
| Working Capital Days | 56 | 210 |
| ROCE % | 15% |
Continue your research
What Renol Polychem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Biopol Chemicals (Q2 FY27)
Revenue from Operations for the half year ended September 30, 2026: ₹4,509.47 Lakhs . Key results statement takeaways from Biopol Chemicals Ltd's Q2 FY27 result
- Ushanti Colour Chem Ltd (Q2 FY27)
Operating Margin (Profit before tax as % of total revenue): . Key results statement takeaways from Ushanti Colour Chem Ltd's Q2 FY27 results statement — and how
- Tata Chemicals (Q2 FY27)
Quarter Revenue (Q2FY27):** ₹4,177 Cr (vs. Key investor presentation takeaways from Tata Chemicals Ltd's Q2 FY27 investor presentation — and how it ranks agains
- Foseco India (Q2 FY27)
31.95% (EBITDA Rs. Key results statement takeaways from Foseco India Ltd's Q2 FY27 results statement — and how it ranks against sector peers.